The 26 analysts offering 1 year price forecasts for 1801 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 32 analysts giving stock ratings to 1801 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1801 EPS for the last quarter is −0.26 HKD despite the estimation of −0.27 HKD. In the next quarter EPS is expected to reach −0.20 HKD. Track more of INNOVENT BIOLOGICS INC financials and stay on top of what is up with the company.
According to analysts, 1801 price target is 54.74 HKD with a max estimate of 68.99 HKD and a min estimate of 36.76 HKD. Check if this forecast comes true in a year, meanwhile watch INNOVENT BIOLOGICS INC stock price chart and keep track of the current situation with 1801 news and stock market news.
We've gathered opinions of 32 analysts rating 1801 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.